Continental Advisors’s iShares Biotechnology ETF IBB Stock Holding History

Continental Advisors’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-5,100	Closed	-$835K	–	66
2021 Q2	$835K	Sell	5,100 -6,400	-56%	-$986K	0.38%	50
2021 Q1	$1.73M	Buy	+11,500	New	+$1.83M	0.8%	48
2016 Q1	–	Sell	-7,500	Closed	-$846K	–	140
2015 Q4	$846K	Buy	+7,500	New	+$814K	0.21%	111
2015 Q3	–	Sell	-40,500	Closed	-$4.98M	–	167
2015 Q2	$4.98M	Sell	40,500 -28,500	-41%	-$3.41M	1.32%	23
2015 Q1	$7.9M	Sell	69,000 -93,000	-57%	-$10.3M	1.74%	9
2014 Q4	$16.4M	Buy	162,000 +99,000	+157%	+$9.62M	3.31%	2
2014 Q3	$5.75M	Buy	+63,000	New	+$5.53M	1.31%	13
2014 Q2	–	Sell	-27,000	Closed	-$2.13M	–	137
2014 Q1	$2.13M	Sell	27,000 -151,500	-85%	-$12.6M	0.55%	53
2013 Q4	$13.5M	Sell	178,500 -30,300	-15%	-$2.15M	2.94%	7
2013 Q3	$14.6M	Buy	208,800 +153,300	+276%	+$10M	3.62%	5
2013 Q2	$3.22M	Buy	+55,500	New	+$3.21M	0.91%	33

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Continental Advisors's IBB Position: Q4 2020 in Review

Continental Advisors sold out of iShares Biotechnology ETF (IBB) in Q4 2020, closing a stake of 5,400 shares — an estimated $731K sold.

Continental Advisors first reported a position in IBB in Q2 2013 and held it in 8 quarters. The position peaked at $2.91M in Q4 2014. 856 funds tracked by Wall St. Rank hold IBB as of Q4 2020.

Continental Advisors reported no remaining iShares Biotechnology ETF position as of Q4 2020 after selling out during the quarter.
Continental Advisors sold 5,400 iShares Biotechnology ETF shares in Q4 2020, an estimated $731K.
Continental Advisors first reported a position in iShares Biotechnology ETF in Q2 2013 and held it in 8 quarters.
Continental Advisors's iShares Biotechnology ETF position peaked at $2.91M in Q4 2014.
856 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2020.

Based on Continental Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.